stockrow
Monday 9 November 2026
Export VRXA’s income statement to Excel — free account
Veraxa Biotech AG
VRXA
0.95
0.00
0.00%
Follow VRXA
Alert me
Veraxa Biotech AG (VRXA) Return on invested capital
Return on invested capital, annual
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| INO Inovio Pharmaceuticals, Inc. compare | 0.00% |
| MSLE Satellos Bioscience Inc. compare | 0.00% |
| CUE Cue Biopharma, Inc. compare | 0.00% |
| ANTX AN2 Therapeutics, Inc. compare | 0.00% |
| ADAG Adagene Inc. Sponsored ADR compare | 0.00% |
| MGNX MacroGenics, Inc. compare | 0.00% |
| NGEN NervGen Pharma Corp. compare | 0.00% |
| SION Sionna Therapeutics, Inc. compare | −125.0% |
| VRXA Veraxa Biotech AG | — |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)